Natalia Manilo

990 total citations
8 papers, 157 citations indexed

About

Natalia Manilo is a scholar working on Rheumatology, Immunology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Natalia Manilo has authored 8 papers receiving a total of 157 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Rheumatology, 5 papers in Immunology and 2 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Natalia Manilo's work include Rheumatoid Arthritis Research and Therapies (6 papers), Spondyloarthritis Studies and Treatments (4 papers) and Psoriasis: Treatment and Pathogenesis (3 papers). Natalia Manilo is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (6 papers), Spondyloarthritis Studies and Treatments (4 papers) and Psoriasis: Treatment and Pathogenesis (3 papers). Natalia Manilo collaborates with scholars based in Denmark, United States and Sweden. Natalia Manilo's co-authors include Niels Steen Krogh, Anne Gitte Loft, Merete Lund Hetland, Bente Glintborg, Hanne Lindegaard, Claus Rasmussen, Dorte Vendelbo Jensen, Henrik Nordin, L. Ejstrup and P.M. Petersen and has published in prestigious journals such as Annals of the Rheumatic Diseases, Lara D. Veeken and International Journal of Rheumatic Diseases.

In The Last Decade

Natalia Manilo

7 papers receiving 153 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Natalia Manilo Denmark 5 137 88 55 11 9 8 157
Mette Holland‐Fischer Denmark 5 212 1.5× 172 2.0× 102 1.9× 6 0.5× 12 1.3× 8 242
Washington A. Bianchi Brazil 5 79 0.6× 40 0.5× 49 0.9× 3 0.3× 6 0.7× 6 108
Iain McInnes Denmark 3 71 0.5× 61 0.7× 39 0.7× 3 0.3× 3 0.3× 3 98
José Chávez-Corrales Peru 4 74 0.5× 59 0.7× 39 0.7× 2 0.2× 7 0.8× 5 87
Chris Thompson United States 3 61 0.4× 39 0.4× 19 0.3× 2 0.2× 8 0.9× 4 74
E. Galíndez Spain 6 98 0.7× 70 0.8× 40 0.7× 6 0.7× 21 117
Jane Leeder United Kingdom 3 106 0.8× 58 0.7× 38 0.7× 4 0.4× 3 116
Laurence Carton France 4 99 0.7× 59 0.7× 29 0.5× 1 0.1× 3 0.3× 12 110
Susanne Schmitt United States 3 23 0.2× 55 0.6× 16 0.3× 23 2.1× 17 1.9× 4 63
Musaab Elmamoun United Kingdom 5 63 0.5× 64 0.7× 38 0.7× 4 0.4× 8 94

Countries citing papers authored by Natalia Manilo

Since Specialization
Citations

This map shows the geographic impact of Natalia Manilo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Natalia Manilo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Natalia Manilo more than expected).

Fields of papers citing papers by Natalia Manilo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Natalia Manilo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Natalia Manilo. The network helps show where Natalia Manilo may publish in the future.

Co-authorship network of co-authors of Natalia Manilo

This figure shows the co-authorship network connecting the top 25 collaborators of Natalia Manilo. A scholar is included among the top collaborators of Natalia Manilo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Natalia Manilo. Natalia Manilo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
2.
Glinatsi, Daniel, Cecilie Heegaard Brahe, Merete Lund Hetland, et al.. (2020). Association between MRI findings and patient‐reported outcomes in patients with rheumatoid arthritis in clinical remission and at relapse. International Journal of Rheumatic Diseases. 23(4). 488–498. 5 indexed citations
3.
Glintborg, Bente, Inge Juul Sørensen, Dorte Vendelbo Jensen, et al.. (2016). OP0225 Three Months' Clinical Outcomes from A Nationwide Non-Medical Switch from Originator To Biosimilar Infliximab in Patients with Inflammatory Arthritis. Results from The Danbio Registry. Annals of the Rheumatic Diseases. 75. 142–142. 4 indexed citations
4.
Brahe, Cecilie Heegaard, Lene Terslev, Simon Krabbe, et al.. (2016). AB0263 Agreement between Das28, Acr/eular, Sdai, Cdai and Ultrasound Remission in Patients with Rheumatoid Arthritis Receiving Biological Treatment in Routine Care. Annals of the Rheumatic Diseases. 75. 989–990. 1 indexed citations
5.
Guðbjörnsson, Björn, Niels Steen Krogh, Emina Omerovic, et al.. (2014). Impact of different infliximab dose regimens on treatment response and drug survival in 462 patients with psoriatic arthritis: results from the nationwide registries DANBIO and ICEBIO. Lara D. Veeken. 53(11). 2100–2109. 24 indexed citations
6.
Glintborg, Bente, Björn Guðbjörnsson, Niels Steen Krogh, et al.. (2013). Impact Of Low Infliximab Dose Regimen On Treatment Response and Drug Survival In 462 Patients With Psoriatic Arthritis: Results From The Nationwide Registries Danbio and Icebio. VBN Forskningsportal (Aalborg Universitet). 65.
7.
Glintborg, Bente, Mikkel Østergaard, Niels Steen Krogh, et al.. (2012). Clinical response, drug survival and predictors thereof in 432 ankylosing spondylitis patients after switching tumour necrosis factor α inhibitor therapy: results from the Danish nationwide DANBIO registry. Annals of the Rheumatic Diseases. 72(7). 1149–1155. 105 indexed citations
8.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mette Holland‐Fischer Breakdown of academic impact, for papers by Washington A. Bianchi Breakdown of academic impact, for papers by Iain McInnes Breakdown of academic impact, for papers by José Chávez-Corrales Breakdown of academic impact, for papers by Chris Thompson Breakdown of academic impact, for papers by E. Galíndez Breakdown of academic impact, for papers by Jane Leeder Breakdown of academic impact, for papers by Laurence Carton Breakdown of academic impact, for papers by Susanne Schmitt Breakdown of academic impact, for papers by Musaab Elmamoun
Rankless by CCL
2026